M. Baliker reports being an employee of Baliker Healthcare Consulting; ownership interest in CareDx and Exact Science; and honoraria from the American Kidney Fund, CareDx, the Department of Defense, and Talaris Therapeutics. G. Roberts reports being an employee of the University of Washington (UW), Center for Dialysis Innovation; UW Justice, Equity, Diversity, and Inclusion Center for Transformative Research; UW, Kidney Research Institute; ownership interest in Options Unlimited International (50% ownership) a management consulting firm; and is a member of the “Preparing for the Future: Creating Ethics Frameworks for Xenotransplant Implementation Working Group” under the auspices of the Division of Medical Ethics at New York University, within the Department of Population Health’s sub-entity Transplant Ethics and Policy Research."